Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;9(3):311-4.
Epub 2009 Dec 19.

Serum level of heart-type Fatty Acid-binding protein in patients with chronic renal failure

Hafidh A Al-Hadi  1 , Brent William, Keith A Fox
Affiliations

Serum level of heart-type Fatty Acid-binding protein in patients with chronic renal failure

Hafidh A Al-Hadi et al. Sultan Qaboos Univ Med J. 2009 Dec.

Abstract

Objectives: Heart-type fatty acid binding-protein (H-FABP) has been reported to be a potential novel biochemical marker for the early diagnosis of acute myocardial infarction (AMI). The effect of kidney diseases on the renal handling of H-FABP has not yet been fully evaluated. The aim of this study was to compare the effect of renal failure on the level of H-FABP and cardiac troponin (cTnT) concentrations.

Methods: The study population was a small group of 16 patients with renal failure (6 females, 10 males aged 30-70 years) on routine regular haemodialysis or peritoneal dialysis.

Results: The mean ±SD of serum urea and creatinine concentration in this group of patients was 19 ±9.6 mmol/L and 531.3 ±231.2 mmol/L respectively. H-FABP was increased in all 16 patients (81 ±53.3μg/L). The cTnT was increased ≥ 0.1μg/L in 8 patients (50%), ≥ 0.2μg/L in 5 patients (31.3%), and ≥ 0.3μg/L in 1 patient (6%).

Conclusion: The diagnostic efficiency of H-FABP and cTnT for the diagnosis of AMI in the presence of renal failure may be limited and such patients may have high levels even in the absence of AMI.

Keywords: Cardiac troponin T; Heart-type fatty acid-binding protein; Renal failure.

PubMed Disclaimer

References

    1. Glatz JF, Van Bilsen M, Paulussen RJ, Veerkamp JH, Van der Vusse GJ, Reneman RS, et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta. 1988;961:148–52. - PubMed
    1. Yoshimoto K, Tanaka T, Somiya K, Tsuji R, Okamoto F, Kawamura K, et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels. 1995;10:304–9. - PubMed
    1. Colli A, Jossa M, Pomar JL, Mestres CA, Gharli T. Heart fatty acid binding proteins in diagnosis of myocardial infarction: where do we stand now? Cardiology. 2007;108:4–10. - PubMed
    1. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem. 1992;116:155–62. - PubMed
    1. Abe S, Okino H, Lee S, Toda H, Miyata M, Nomoto K, et al. Human heart fatty acid-binding protein. A sensitive and specific marker of coronary reperfusion. Circulation. 1991;84:II–291.

LinkOut - more resources